These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 4822972

  • 1. Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa.
    Parkes JD, Marsden CD, Rees JE, Curzon G, Kantamaneni BD, Knill-Jones R, Akbar A, Das S, Kataria M.
    Q J Med; 1974 Jan; 43(169):49-61. PubMed ID: 4822972
    [No Abstract] [Full Text] [Related]

  • 2. Parkinson's disease: a clinical review.
    Lieberman AN.
    Am J Med Sci; 1974 Feb; 267(2):66-80. PubMed ID: 4821328
    [No Abstract] [Full Text] [Related]

  • 3. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
    van Woert MH, Bowers MB.
    Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534981
    [No Abstract] [Full Text] [Related]

  • 4. Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases.
    Mark MH, Sage JI, Walters AS, Duvoisin RC, Miller DC.
    Mov Disord; 1995 Jul; 10(4):450-4. PubMed ID: 7565825
    [Abstract] [Full Text] [Related]

  • 5. Predictive factors for cognitive deterioration and dementia in Parkinson's disease.
    Portin R, Rinne UK.
    Adv Neurol; 1987 Jul; 45():413-6. PubMed ID: 3825718
    [No Abstract] [Full Text] [Related]

  • 6. Clinical observations in early and late onset Parkinson's disease.
    Bostantjopoulou S, Logothetis J, Katsarou Z, Mentenopoulos G.
    Funct Neurol; 1991 Jul; 6(2):145-9. PubMed ID: 1916456
    [Abstract] [Full Text] [Related]

  • 7. Levodopa and L-tryptophan therapy in Parkinsonism.
    Coppen A, Metcalfe M, Carroll JD, Morris JG.
    Lancet; 1972 Mar 25; 1(7752):654-8. PubMed ID: 4125162
    [No Abstract] [Full Text] [Related]

  • 8. [L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2].
    Sano I, Taniguchi K.
    Munch Med Wochenschr; 1972 Oct 06; 114(40):1717-9. PubMed ID: 4538893
    [No Abstract] [Full Text] [Related]

  • 9. [Biochemical and clinical correlations in Parkinson's disease].
    Barbeau A.
    Rev Neurol (Paris); 1972 Aug 06; 127(2):253-64. PubMed ID: 4603361
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
    Rosati G, Agnetti V, Mura F, Granieri E.
    Minerva Med; 1974 May 02; 65(33):1811-23. PubMed ID: 4602058
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S, Nagaswami R.
    Dis Nerv Syst; 1973 May 02; 34(5):253-8. PubMed ID: 4782280
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The probenecid test in Parkinson's disease.
    Lakke JP, Korf J, Hoorntje S, Schut T, van Praag HM.
    Psychiatr Neurol Neurochir; 1973 May 02; 76(2):139-46. PubMed ID: 4700931
    [No Abstract] [Full Text] [Related]

  • 15. The natural history of Parkinson's disease.
    Selby G.
    Aust Fam Physician; 1984 May 02; 13(5 Suppl):1-3. PubMed ID: 6497764
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [New methods for measurement of the tremor and rigidity in patients with Parkinson's disease treated with L-Dopa].
    Paci A, Freddi A, Barba C.
    Riv Neurol; 1973 May 02; 43(1):15-39. PubMed ID: 4698011
    [No Abstract] [Full Text] [Related]

  • 18. Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease.
    Sweet RD, McDowell FH.
    Neurology; 1974 Oct 02; 24(10):953-6. PubMed ID: 4472237
    [No Abstract] [Full Text] [Related]

  • 19. [Parkinson's disease: neuro-anatomical, biochemical and pharmicotherapeutic aspects].
    Korf J, van Praagen HM, Lakke JP.
    Ned Tijdschr Geneeskd; 1975 Sep 06; 119(36):1373-8. PubMed ID: 241026
    [No Abstract] [Full Text] [Related]

  • 20. The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.
    West KA, Roos BE.
    Confin Neurol; 1972 Sep 06; 34(2):136-42. PubMed ID: 4579783
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.